Macquarie Group LTD Haemonetics Corp Transaction History

Macquarie Group LTD

  • $85.1 Billion
  • Q2 2024

A detailed history of Macquarie Group LTD transactions in Haemonetics Corp stock. As of the latest transaction made, Macquarie Group LTD holds 41,524 shares of HAE stock, worth $3.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,524
Previous 44,952 7.63%
Holding current value
$3.11 Million
Previous $3.84 Million 10.45%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
SELL
$81.24 - $97.37 $278,490 - $333,784
-3,428 Reduced 7.63%
41,524 $3.44 Million
Q1 2024

May 14, 2024
BUY
$71.24 - $85.35 $493,479 - $591,219
6,927 Added 18.22%
44,952 $3.84 Million
Q4 2023

Feb 14, 2024
BUY
$80.59 - $92.61 $445,662 - $512,133
5,530 Added 17.02%
38,025 $3.25 Million
Q3 2023

Nov 14, 2023
BUY
$82.56 - $93.49 $52,343 - $59,272
634 Added 1.99%
32,495 $2.91 Million
Q2 2023

Aug 14, 2023
BUY
$80.84 - $89.45 $152,545 - $168,792
1,887 Added 6.3%
31,861 $2.71 Million
Q1 2023

May 15, 2023
BUY
$72.75 - $90.6 $161,941 - $201,675
2,226 Added 8.02%
29,974 $2.48 Million
Q4 2022

Feb 21, 2023
SELL
$73.85 - $86.14 $949,120 - $1.11 Million
-12,852 Reduced 31.66%
27,748 $2.18 Million
Q3 2022

Nov 14, 2022
SELL
$63.3 - $78.66 $342,959 - $426,179
-5,418 Reduced 11.77%
40,600 $3.05 Million
Q2 2022

Aug 15, 2022
BUY
$49.27 - $66.08 $2,512 - $3,370
51 Added 0.11%
46,018 $3 Million
Q1 2022

May 16, 2022
BUY
$43.77 - $63.22 $61,803 - $89,266
1,412 Added 3.17%
45,967 $2.91 Million
Q4 2021

Feb 11, 2022
BUY
$49.55 - $74.59 $51,482 - $77,499
1,039 Added 2.39%
44,555 $2.36 Million
Q3 2021

Nov 12, 2021
BUY
$57.6 - $70.59 $292,089 - $357,961
5,071 Added 13.19%
43,516 $3.07 Million
Q2 2021

Aug 13, 2021
BUY
$51.81 - $118.56 $167,968 - $384,371
3,242 Added 9.21%
38,445 $2.56 Million
Q1 2021

May 14, 2021
BUY
$111.01 - $139.48 $3.59 Million - $4.52 Million
32,379 Added 1146.57%
35,203 $3.91 Million
Q3 2020

Nov 13, 2020
SELL
$75.65 - $93.58 $12.7 Million - $15.7 Million
-167,854 Reduced 98.35%
2,824 $246,000
Q2 2020

Aug 11, 2020
BUY
$84.96 - $118.91 $4.11 Million - $5.75 Million
48,362 Added 39.54%
170,678 $15.3 Million
Q1 2020

May 15, 2020
SELL
$74.34 - $121.82 $1.04 Million - $1.71 Million
-13,999 Reduced 10.27%
122,316 $12.2 Million
Q4 2019

Feb 14, 2020
BUY
$114.37 - $129.46 $1.35 Million - $1.53 Million
11,837 Added 9.51%
136,315 $15.7 Million
Q3 2019

Nov 14, 2019
SELL
$117.16 - $138.52 $1.15 Million - $1.36 Million
-9,849 Reduced 7.33%
124,478 $15.7 Million
Q2 2019

Aug 14, 2019
BUY
$81.74 - $120.34 $1.85 Million - $2.73 Million
22,652 Added 20.28%
134,327 $16.2 Million
Q1 2019

May 15, 2019
SELL
$83.25 - $102.12 $4.13 Million - $5.07 Million
-49,633 Reduced 30.77%
111,675 $9.77 Million
Q4 2018

Feb 15, 2019
SELL
$90.66 - $116.63 $226,740 - $291,691
-2,501 Reduced 1.53%
161,308 $16.1 Million
Q3 2018

Nov 15, 2018
SELL
$89.96 - $114.58 $32.7 Million - $41.7 Million
-363,769 Reduced 68.95%
163,809 $18.8 Million
Q2 2018

Aug 14, 2018
SELL
$71.53 - $95.75 $6.99 Million - $9.36 Million
-97,757 Reduced 15.63%
527,578 $47.3 Million
Q1 2018

May 11, 2018
SELL
$60.72 - $74.41 $3.15 Million - $3.86 Million
-51,815 Reduced 7.65%
625,335 $45.7 Million
Q4 2017

Feb 15, 2018
SELL
$44.96 - $58.99 $266,208 - $349,279
-5,921 Reduced 0.87%
677,150 $39.3 Million
Q3 2017

Nov 08, 2017
BUY
$40.38 - $44.87 $27.6 Million - $30.6 Million
683,071
683,071 $30.7 Million

Others Institutions Holding HAE

# of Institutions
337
Shares Held
55.2M
Call Options Held
383K
Put Options Held
45.1K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.84B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email